5 CONCLUSIONS
Based on this study, Sarcopenia in Indonesia can be
determined by cut-off point from young adult values
for the ASM; <8,1 Kg/M
2
(male) and <5,6 Kg/M
2
(female), the HGS; < 32 Kg (male) and <20 Kg
(female), and the GS; < 1,2 M/sec (male) and < 1,17
(female).
The values of the ASM, HGS, and GS in elderly
male subjects from community dwelling were higher
than values obtained from subjects in nursing home
setting. While the ASM and HGS results in elderly
female subjects were quite similar between both
location, however, elderly female subjects from
community dwelling group have higher GS
compared to the elderly female subjects in the
nursing home. The percentage of the lower ASM in
elderly male and female subjects were significantly
higher in nursing home setting than community
dwelling home.
The physical performance in this study presented
by gait speed was better in elderly who lived in
community dwelling home in both gender.
ACKNOWLEDGEMENT
This study was support by Research Institution of
Trisakti University. The authors subsequently
present their sincere gratitude to the Director of Sari
Asih Hospital Ciputat Tangerang, The Head of
Budhi Mulya 2 Social Care Institution Cengkareng
for facilitating this study, and also the highest
appreciation to all of the students from the
university, the elderly subjects from the community
dwelling group and the elderly subjects from the
nursing home who participated in this study.
REFFERENCES
Moreira, V.G., Perez, M. and Lourenço, R.A. 2019.
Prevalence of sarcopenia and its associated factors: the
impact of muscle mass, gait speed, and handgrip
strength reference values on reported frequencies.
Clinics (Sao Paulo, Brazil), [online] 74, p.e477.
Available at:
https://www.ncbi.nlm.nih.gov/pubmed/30994709.
Shafiee, G., Keshtkar, A., Soltani, A., Ahadi, Z., Larijani,
B. and Heshmat, R. 2017. Prevalence of sarcopenia in
the world: a systematic review and meta- analysis of
general population studies. Journal of Diabetes &
Metabolic Disorders, [online] 16(1). Available at:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434
551.
Rodríguez-Rejón, A.I., Ruiz-López, M.D., Wanden-
Berghe, C. and Artacho, R. 2019. Prevalence and
Diagnosis of Sarcopenia in Residential Facilities: A
Systematic Review. Advances in nutrition (Bethesda,
Md.), [online] 10(1), pp.51–58. Available at:
https://www.ncbi.nlm.nih.gov/pubmed/30668619.
Abe, T., Sakamaki, M., Yasuda, T., Bemben, M.G.,
Kondo, M., Kawakami, Y. and Fukunaga, T. 2011.
Age-related, site-specific muscle loss in 1507 Japanese
men and women aged 20 to 95 years. Journal of sports
science & medicine, [online] 10(1), pp.145–50.
Available at:
https://www.ncbi.nlm.nih.gov/pubmed/24149307.
Milanović, Z., Pantelić, S., Trajković, N., Sporiš, G.,
Kostić, R. and James, N. 2013. Age-related decrease
in physical activity and functional fitness among
elderly men and women. Clinical interventions in
aging, [online] 8, pp.549–56. Available at:
https://www.ncbi.nlm.nih.gov/pubmed/23723694.
Santilli, V., Bernetti, A., Mangone, M. and Paoloni, M.
2014. Clinical definition of sarcopenia. Clinical cases
in mineral and bone metabolism : the official journal
of the Italian Society of Osteoporosis, Mineral
Metabolism, and Skeletal Diseases, [online] 11(3),
pp.177–80. Available at:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269
139/.
Lees, M.J., Wilson, O.J., Hind, K. and Ispoglou, T. 2019.
Muscle quality as a complementary prognostic tool in
conjunction with sarcopenia assessment in younger
and older individuals. European Journal of Applied
Physiology, 119(5), pp.1171–1181.
Yeung, S.S.Y., Reijnierse, E.M., Pham, V.K.,
Trappenburg, M.C., Lim, W.K., Meskers, C.G.M. and
Maier, A.B. 2019. Sarcopenia and its association with
falls and fractures in older adults: A systematic review
and meta-analysis. Journal of cachexia, sarcopenia
and muscle, [online] 10(3), pp.485–500. Available at:
https://www.ncbi.nlm.nih.gov/pubmed/30993881.
Chumlea, W.C., Cesari, M., Evans, W.J., Ferrucci, L.,
Fielding, R.A., Pahor, M., Studenski, S., Vellas, B.
and International Working Group on Sarcopenia Task
Force Members. 2011. Sarcopenia: designing phase
IIB trials. The journal of nutrition, health & aging,
[online] 15(6), pp.450–5. Available at:
https://www.ncbi.nlm.nih.gov/pubmed/21623466.
Chen, L.-K., Liu, L.-K., Woo, J., Assantachai, P.,
Auyeung, T.-W., Bahyah, K.S., Chou, M.-Y., Chen,
L.-Y., Hsu, P.-S., Krairit, O., Lee, J.S.W., Lee, W.-J.,
Lee, Y., Liang, C.-K., Limpawattana, P., Lin, C.-S.,
Peng, L.-N., Satake, S., Suzuki, T., Won, C.W., Wu,
C.-H., Wu, S.-N., Zhang, T., Zeng, P., Akishita, M.
and Arai, H. 2014. Sarcopenia in Asia: consensus
report of the Asian Working Group for Sarcopenia.
Journal of the American Medical Directors
Association, [online] 15(2), pp.95–101. Available at:
https://www.ncbi.nlm.nih.gov/pubmed/24461239.